A systematic review of health economic evaluations of vaccines in Brazil
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review of health economic evaluations of vaccines in Brazil
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 6, Pages 1454-1465
Publisher
Informa UK Limited
Online
2017-01-28
DOI
10.1080/21645515.2017.1282588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost–effectiveness thresholds: pros and cons
- (2016) Melanie Y Bertram et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil
- (2016) Ana Marli Christovam Sartori et al. VACCINE
- Economic evaluation of vaccines in Canada: A systematic review
- (2016) Ayman Chit et al. Human Vaccines & Immunotherapeutics
- Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
- (2016) Mark Jit et al. Applied Health Economics and Health Policy
- Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
- (2015) Bernhard Ultsch et al. PHARMACOECONOMICS
- Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?
- (2015) Xiong-Fei Pan et al. VACCINE
- Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil
- (2015) Hillegonda Maria Dutilh Novaes et al. VACCINE
- Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience
- (2015) Barbara Jauregui et al. VACCINE
- ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions
- (2015) Barbara Jauregui et al. VACCINE
- Polio inactivated vaccine costs into routine childhood immunization in Brazil
- (2015) Ana Marli Christovam Sartori et al. REVISTA DE SAUDE PUBLICA
- Thresholds for the cost–effectiveness of interventions: alternative approaches
- (2015) Elliot Marseille et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines
- (2014) A. T. Newall et al. PHARMACOECONOMICS
- Valuing vaccination
- (2014) T. Barnighausen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic Review of Economic Evaluation of Health Technologies Developed In Brazil From 1980-2013
- (2014) T.C. Decimoni et al. VALUE IN HEALTH
- What matters most?: evidence-based findings of health dimensions affecting the societal preferences for EQ-5D health states
- (2013) Monica Viegas Andrade et al. Cadernos de Saude Publica
- When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
- (2013) Ferrán Catalá-López et al. PLoS One
- Cost-effectiveness of the vaccine against human papillomavirus in the Brazilian Amazon region
- (2013) Allex Jardim da Fonseca et al. Revista da Associacao Medica Brasileira
- Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience
- (2013) C.M. Toscano et al. VACCINE
- Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain?
- (2013) Anna García-Altés VACCINE
- Dengue dynamics and vaccine cost-effectiveness in Brazil
- (2013) David P. Durham et al. VACCINE
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Economics of vaccines revisited
- (2013) Maarten J. Postma et al. Human Vaccines & Immunotherapeutics
- Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model
- (2012) Kosuke Kawai et al. BMC INFECTIOUS DISEASES
- Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus
- (2012) T. Bärnighausen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Financial Relationships in Economic Analyses of Targeted Therapies in Oncology
- (2012) Antonis Valachis et al. JOURNAL OF CLINICAL ONCOLOGY
- Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: A dynamic individual-based approach
- (2012) Tazio Vanni et al. VACCINE
- Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: Regional analyses according to the endemic context
- (2012) Ana Marli C. Sartori et al. VACCINE
- Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil
- (2011) Joao Tonolio Neto et al. Human vaccines & immunotherapeutics
- Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial
- (2011) Susan M Pereira et al. LANCET INFECTIOUS DISEASES
- Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans
- (2011) Piia K. Peura et al. MEDICAL DECISION MAKING
- Challenges in Health State Valuation in Paediatric Economic Evaluation
- (2011) Wendy J. Ungar PHARMACOECONOMICS
- Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil
- (2011) Patricia Coelho de Soarez et al. VALUE IN HEALTH
- Estimating the SF-6D Value Set for a Population-Based Sample of Brazilians
- (2011) Luciane N. Cruz et al. VALUE IN HEALTH
- Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
- (2010) Sekwon Jang et al. BREAST CANCER RESEARCH AND TREATMENT
- Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil
- (2010) Ana Marli Christovam Sartori et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Does the Funding Source Influence the Results in Economic Evaluations?
- (2010) Rachael L. Fleurence et al. PHARMACOECONOMICS
- What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?
- (2010) Marco Barbieri et al. VALUE IN HEALTH
- Cost-Effectiveness Analyses of Hepatitis A Vaccine
- (2009) Andrea M Anonychuk et al. PHARMACOECONOMICS
- Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations
- (2009) Sonya J. Snedecor et al. VACCINE
- WHO Guide for standardisation of economic evaluations of immunization programmes
- (2009) Damian G. Walker et al. VACCINE
- The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine
- (2008) Daniel J. Isaacman et al. CLINICAL THERAPEUTICS
- Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy
- (2008) E. MASSAD et al. EPIDEMIOLOGY AND INFECTION
- Funding of drugs: do vaccines warrant a different approach?
- (2008) Philippe Beutels et al. LANCET INFECTIOUS DISEASES
- Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil
- (2008) J. Valentim et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More